Modeling and Scenario Analysis for Pharmaceutical R&D at Pfizer

Requirements:

1. Develop a financial model for Pfizer to evaluate R&D investments in pharmaceutical drug development.

Financial Metrics	Amount ($)
Research Expenditures	3,000,000,000
Drug Development Costs	5,000,000,000
Expected Revenue	10,000,000,000
Valuation Multiple	30x

2. Perform scenario analysis to assess the impact of clinical trial outcomes and regulatory approvals on drug development timelines and financial projections.
3. Calculate key financial ratios such as return on investment (ROI) and payback period to evaluate R&D project viability.
4. Recommend investment decisions and strategic initiatives to optimize Pfizer's pharmaceutical R&D portfolio.